A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
A phase 2 trial of Docetaxel, Bevacizumab, Pemetrexed and Carboplatin in advanced solid tumours, run by Nanjing Leads Biolabs Co.,Ltd, now recruiting.
Overview
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)] is a phase 2 interventional study registered as NCT06783647 by Nanjing Leads Biolabs Co.,Ltd, with 250 participants planned, started 2025-06-11 and due to reach its primary completion in 2026-12-24. Interventions recorded: LBL-024 for Injection, Docetaxel Injection, Bevacizumab Injection, Pemetrexed Disodium for Injection, Paclitaxel Injection and Carboplatin Injection.
Similar pages
not linked directly; found by shared links- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Shares Nanjing Leads Biolabs, Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
Shares Nanjing Leads Biolabs, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
Shares Docetaxel, Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
Shares Bevacizumab, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
Shares Docetaxel, Pemetrexed, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
Shares Docetaxel, Pemetrexed, Carboplatin and the tag pipeline.
- TrialTo Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
Shares Pemetrexed, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Shares Pemetrexed, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.